Voya Financial, Inc. VOYA Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001535929-25-000040
cik 1535929
name VOYA FINANCIAL, INC.
sic 6311
countryba US
stprba NY
cityba NEW YORK
zipba 10166
bas1 200 PARK AVENUE
bas2
baph 212-309-8200
countryma US
stprma NY
cityma NEW YORK
zipma 10166
mas1 200 PARK AVENUE
mas2
countryinc US
stprinc DE
ein 521222820
former ING U.S., INC.
changed 20120709
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250508
accepted 2025-05-08 16:18:00.0
prevrpt 0
detail 1
instance voya-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001535929-25-000040 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1514000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Additional Paid In Capital Common Stock 6299000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value -4000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Allowance For Doubtful Other Receivables Current 1000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Assets 24940000000.0000 USD 0 us-gaap/2025 Business Segments= Corporate;
0001535929-25-000040 20241231 Assets 2588000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Assets 3423000000.0000 USD 0 us-gaap/2025 Business Segments= Employee Benefits; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Available For Sale Securities Debt Securities Using Fair Value Option 1854000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Cash Acquired From Acquisition 274000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Cash And Cash Equivalents At Carrying Value 1399000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1514000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Collateralized Financings Consolidated Investment Entities 0.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Collateralized Financings Consolidated Investment Entities 0.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Collateralized Financings Consolidated Investment Entities 1028000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Common Stock Shares Issued 106813254.0000 shares 0 us-gaap/2025
0001535929-25-000040 20241231 Common Stock Shares Outstanding 95500000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20250331 Common Stock Value 1000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -15000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 524000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 28079000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 3021000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2846000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 3942000000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 8313000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 635000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2746000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 30000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 60000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 67000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 59000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2769000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4983000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2537000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4983000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 26361000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2562000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1677000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2788000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 249000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 2000000.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 332000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Derivative; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 19000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Stabilizer And M C Gs; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 19000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Stabilizer And M C Gs; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 3000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20240331 Dividends Preferred Stock 17000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Earnings Per Share Diluted 1.4200 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 4675000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20231231 Goodwill 748000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Goodwill 748000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities 35000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Investments 37703000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Minority Interest Period Increase Decrease -4000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20250331 Net Cash Provided By Used In Investing Activities 245000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Income Loss 251000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Investment Income 38000000.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 0.0000 USD 1 0001535929-25-000040 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 0.0000 USD 1 0001535929-25-000040 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 78000000.0000 USD 1 0001535929-25-000040 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 22000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 1486000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Other Assets 3276000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent 344000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Comprehensive Income Loss Net Of Tax 281000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20240331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Other Noninterest Expense 23000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20250331 Other Noninterest Expense 22000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20250331 Proceeds From Divestiture Of Interest In Consolidated Subsidiaries 372000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Sale Of Equity Securities Fv Ni 48000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Other Derivatives Net;
0001535929-25-000040 20240331 Realized Investment Gains Losses 3000000.0000 USD 1 us-gaap/2025 Financial Instrument= Equity Securities;
0001535929-25-000040 20250331 Realized Investment Gains Losses -34000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20250331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Financial Instrument= Fixed Maturities Available For Sale Including Securities Pledged;
0001535929-25-000040 20250331 Realized Investment Gains Losses -6000000.0000 USD 1 us-gaap/2025 Investment Type= Mortgages;
0001535929-25-000040 20250331 Repayments Of Debt Maturing In More Than Three Months 400000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Retained Earnings Unappropriated 1052000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Separate Account Assets 3087000000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises; Separate Account Asset Category= Separate Account Mortgage Backed Security;
0001535929-25-000040 20241231 Separate Account Assets 437000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Separate Account Cash And Cash Equivalents;
0001535929-25-000040 20250331 Separate Account Assets 473000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Separate Account Cash And Cash Equivalents;
0001535929-25-000040 20241231 Separate Accounts Liability 90756000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Deferred Variable Annuity;
0001535929-25-000040 20250331 Separate Accounts Liability 7069000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Wealth Solutions Stabilizer;
0001535929-25-000040 20250331 Short Term Borrowings 1000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -263000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5788000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4005000000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6299000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20231231 Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 175000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Treasury Stock Common Shares -700000.0000 shares 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20240331 Treasury Stock Value Acquired Cost Method 172000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -2100000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Fixed Maturities;
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 41000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value -34000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20241231 Assets 99007000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Common Stock Shares Outstanding 96257262.0000 shares 0 us-gaap/2025
0001535929-25-000040 20241231 Assets 132269000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Assets 163950000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Available For Sale Securities Debt Securities Using Fair Value Option 1849000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 1502000000.0000 USD 0 0001535929-25-000040 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Benefits Losses And Expenses 1796000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Cash And Cash Equivalents At Carrying Value 115000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20250331 Cash And Cash Equivalents At Carrying Value 868000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1010000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 58000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Collateralized Financings Consolidated Investment Entities 1101000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Collateralized Financings Consolidated Investment Entities 1028000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Common Stock Shares Authorized 900000000.0000 shares 0 us-gaap/2025
0001535929-25-000040 20231231 Common Stock Shares Outstanding 102900000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20240331 Comprehensive Income Net Of Tax 182000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Comprehensive Income Net Of Tax 437000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 30000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 9000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 2000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 4000000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 31435000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 24089000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 23000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3132000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3471000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 30000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2983000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 590000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 48000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3115000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3002000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3115000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 5448000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Deferred Policy Acquisition Costs And Present Value Of Future Profits Amortization1 62000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Derivative Assets 2000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 246000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 249000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 332000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 8000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 11000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 286000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Earnings Per Share Basic 2.2900 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 5585000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 1066000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20241231 Goodwill 17000000.0000 USD 0 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Income Tax Expense Benefit -1000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Insurance Commissions And Fees 513000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Liabilities 11000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Liabilities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 251000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 251000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20240331 Net Investment Income 529000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Investment Income 36000000.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Net Investment Income 471000000.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 0.0000 USD 1 0001535929-25-000040 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities 36000000.0000 USD 1 0001535929-25-000040 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 241000000.0000 USD 0 us-gaap/2025 Financial Instrument= Short Term Investments;
0001535929-25-000040 20250331 Other Income 104000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Other Investments 74000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Other Investments 69000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Other Liabilities 2886000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20240331 Other Noninterest Expense 1000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments Of Dividends Common Stock 43000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Assets Investing Activities 462000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Equity Securities Fv Ni 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Limited Partnership Interests 75000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Policyholder Benefits And Claims Incurred Net 579000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Premiums Earned Net 800000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Premiums Receivable And Reinsurance Recoverables Including Reinsurance Premium Paid 11284000000.0000 USD 0 0001535929-25-000040
0001535929-25-000040 20240331 Proceeds From Sale Of Loans Held For Investment 206000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 43000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20240331 Realized Investment Gains Losses 0.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Stabilizer;
0001535929-25-000040 20250331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Repayments Of Debt Maturing In More Than Three Months 0.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Retained Earnings Unappropriated 954000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Separate Account Assets 95946000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Separate Account Assets 101676000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Separate Account Assets 91581000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Separate Account Equity Security;
0001535929-25-000040 20241231 Separate Accounts Liability 97657000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement;
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2400000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -56000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4153000000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1052000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20240331 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20240331 Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 174000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Temporary Equity Other Changes -8000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Treasury Stock Value 754000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1010000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -2181000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Additional Paid In Capital Common Stock 6266000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Additions To Contract Holders Funds 825000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value -35000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20241231 Assets 129058000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Assets 159943000000.0000 USD 0 us-gaap/2025 Business Segments= Total Segment; Equity Components= Parent;
0001535929-25-000040 20250331 Common Stock Shares Issued 106800000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 432000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 6000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 26536000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 3677000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 3709000000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 5672000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3132000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2127000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 1497000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 27454000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2472000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 580000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 27454000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 401000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3115000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 31000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 19000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 533000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 475000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Deferred Income Tax Assets Net 2134000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Deferred Policy Acquisition Costs And Value Of Business Acquired 2148000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 62000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 1000000.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 271000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20240331 Dividends Common Stock Cash 41000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Dividends Common Stock Cash 43000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Dividends Preferred Stock Cash 4000000.0000 USD 1 us-gaap/2025 Class Of Stock= Series B Preferred Stock;
0001535929-25-000040 20250331 Dividends Preferred Stock Cash 4000000.0000 USD 1 us-gaap/2025 Class Of Stock= Series B Preferred Stock;
0001535929-25-000040 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 24000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 287000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Interest Credited To Policyholders Account Balances 256000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Interest Credited To Policyholders Account Balances 226000000.0000 USD 1 us-gaap/2025 Business Segments= Retirement;
0001535929-25-000040 20241231 Liabilities 309000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Liabilities 496000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Long Term Debt Noncurrent 2103000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Minority Interest 1764000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Minority Interest Period Increase Decrease 0.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Net Cash Provided By Used In Operating Activities -179000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 281000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Investment Income 442000000.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Net Investment Income 46000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 78000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities 32000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities 0.0000 USD 1 0001535929-25-000040 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 1309000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 258000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Oci Liability For Future Policy Benefit Gain Loss Before Reclassification Adjustment And Tax 12000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Operating Expenses 799000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Assets 226000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20240331 Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent -125000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments For Proceeds From Short Term Investments 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Mortgage Notes Receivable 257000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Preferred Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Limited Partnership Investments 38000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Other Deposits 69000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Payments To Minority Shareholders 486000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Managed Custody Guarantees;
0001535929-25-000040 20240331 Realized Investment Gains Losses -81000000.0000 USD 1 us-gaap/2025 Financial Instrument= Fixed Maturities At Fair Value Using Fair Value Option;
0001535929-25-000040 20240331 Realized Investment Gains Losses -20000000.0000 USD 1 us-gaap/2025 Financial Instrument= Fixed Maturities Available For Sale Including Securities Pledged;
0001535929-25-000040 20250331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Managed Custody Guarantees;
0001535929-25-000040 20240331 Revenues 2051000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Revenues 1969000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Separate Account Assets 5390000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Separate Account Assets 340000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Separate Account Assets 101676000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20231231 Separate Accounts Liability 7175000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Wealth Solutions Stabilizer;
0001535929-25-000040 20241231 Separate Accounts Liability 4019000000.0000 USD 0 us-gaap/2025 Business Segments= All Other Segments;
0001535929-25-000040 20241231 Short Term Borrowings 399000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1685000000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -788000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20240331 Temporary Equity Comprehensive Income Loss 7000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Temporary Equity Net Income 10000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Withdrawal From Contract Holders Funds 1677000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Withdrawal From Contract Holders Funds 1515000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Additions To Contract Holders Funds 1060000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Assets 3490000000.0000 USD 0 us-gaap/2025 Business Segments= Employee Benefits; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Assets 131059000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Assets 95887000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Assets 2935000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Assets 130740000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1176000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Collateralized Financings Consolidated Investment Entities 1101000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20241231 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Common Stock Shares Issued 105592281.0000 shares 0 us-gaap/2025
0001535929-25-000040 20241231 Common Stock Shares Issued 105600000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20241231 Common Stock Value 1000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Comprehensive Income Loss Net Of Tax Including Portion Attributable To Nonredeemable Noncontrolling Interest 212000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 37000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 182000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 437000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 17000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 9000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 3000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 18000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 1000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 7938000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 511000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 402000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3404000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 421000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2769000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 25978000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2463000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 70000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3002000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2621000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3750000000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 246000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 1000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 1000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 2000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 249000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 2000000.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 1000000.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Dividends Common Stock Cash 43000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Dividends Common Stock Cash 43000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Earnings Per Share Basic 1.4500 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Employee Benefits And Share Based Compensation -1000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 29000000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001535929-25-000040 20231231 Goodwill 343000000.0000 USD 0 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20231231 Goodwill 286000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Goodwill 343000000.0000 USD 0 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Goodwill 102000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20250331 Goodwill 804000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Goodwill 20000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment; Reporting Unit= Health Solutions Segment;
0001535929-25-000040 20250331 Goodwill 10000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment; Reporting Unit= Investment Management Segment;
0001535929-25-000040 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 288000000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0001535929-25-000040 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 173000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Increase Decrease In Collateral Held Under Securities Lending -185000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Investments 35024000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Investments In Affiliates Subsidiaries Associates And Joint Ventures 1836000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Liabilities 276000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Liabilities And Stockholders Equity 163950000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Loans Insurance Policy 342000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20240331 Minority Interest Period Increase Decrease -171000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20250331 Minority Interest Period Increase Decrease -2000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Minority Interest Period Increase Decrease 2000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20240331 Net Cash Provided By Used In Investing Activities 1082000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss Attributable To Noncontrolling Interest -5000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Income Loss Available To Common Stockholders Basic 234000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 156000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Net Investment Income 7000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Operating Expenses 824000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Other Comprehensive Income Loss Net Of Tax -69000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Other Comprehensive Income Loss Net Of Tax -69000000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20250331 Other Comprehensive Income Loss Tax 75000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Other Short Term Investments 94000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20240331 Payments Of Dividends Preferred Stock And Preference Stock 17000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Businesses Net Of Cash Acquired 0.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Mortgage Notes Receivable 107000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Policyholder Contract Deposits 37104000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Payments To Minority Shareholders -150000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Separate Account Assets 101676000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Separate Account Assets 61000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Asset Backed Securities Securitized Loans And Receivables;
0001535929-25-000040 20241231 Separate Account Assets 913000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= U S Treasury And Government;
0001535929-25-000040 20250331 Separate Account Assets 98948000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Separate Account Assets 5196000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Separate Account Assets 1077000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= U S Treasury And Government;
0001535929-25-000040 20250331 Separate Accounts Liability 87919000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Deferred Variable Annuity;
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4193000000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5697000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1544000000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2462000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2181000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4383000000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Accrued Investment Income Receivable 429000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 17000000.0000 USD 1 us-gaap/2025 Class Of Stock= Preferred Stock;
0001535929-25-000040 20250331 Assets 1783000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Management; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Assets 31918000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 1665000000.0000 USD 0 0001535929-25-000040 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Borrowingsof Consolidated Investment Entities 208000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -504000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Collateralized Financings Consolidated Investment Entities 1101000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0001535929-25-000040 20241231 Common Stock Shares Outstanding 95497265.0000 shares 0 us-gaap/2025
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 4000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 2000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2693000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 697000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2887000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 30000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 402000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 27454000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 7008000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3132000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 472000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2198000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3680000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 74000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 59000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 29225000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Debt Securities Available For Sale Restricted 1516000000.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Restricted 1523000000.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities And Other Investment;
0001535929-25-000040 20250331 Deferred Policy Acquisition Costs And Value Of Business Acquired 2505000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 62000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Assets 206000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 332000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Derivative; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 286000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Derivative; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 3000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Dividends Preferred Stock 17000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Dividends Preferred Stock Cash 17000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Dividends Preferred Stock Cash 17000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 29000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Goodwill 102000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20241231 Goodwill 286000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Insurance Commissions And Fees 570000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 1881000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Liabilities And Stockholders Equity 163889000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Net Cash Provided By Used In Financing Activities -570000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Investment Income 5000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Net Investment Income 44000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20240331 Net Investment Income 529000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities 0.0000 USD 1 0001535929-25-000040 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities 32000000.0000 USD 1 0001535929-25-000040 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 1122000000.0000 USD 0 us-gaap/2025 Financial Instrument= Payables Under Securities Loan Agreements;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 321000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 417000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 31000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20240331 Other Income 88000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Other Investments 67000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Other Liabilities 1640000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20250331 Other Noninterest Expense 8000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Other Short Term Investments 149000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20240331 Payments For Proceeds From Derivative Instrument Investing Activities -58000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments For Proceeds From Other Investing Activities 16000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments For Repurchase Of Common Stock 172000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Assets Investing Activities 267000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Available For Sale Securities Debt 504000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Available For Sale Securities Debt 2401000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Equity Securities Fv Ni 9000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments To Acquire Limited Partnership Interests 125000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Preferred Stock Liquidation Preference Value 625000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Preferred Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Premiums Earned Net 737000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Limited Partnership Investments 51000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Other Deposits 33000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Sale Of Equity Securities Fv Ni 26000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 38000000.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Fixed Maturities;
0001535929-25-000040 20250331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Realized Investment Gains Losses 4000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Stabilizer;
0001535929-25-000040 20250331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Standalone Derivatives;
0001535929-25-000040 20250331 Realized Investment Gains Losses 20000000.0000 USD 1 us-gaap/2025 Financial Instrument= Fixed Maturities At Fair Value Using Fair Value Option;
0001535929-25-000040 20240331 Repayment Of Borrowings Of Noncontrolling Interests 52000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20241231 Separate Account Assets 101676000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Separate Account Assets 94685000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Separate Account Equity Security;
0001535929-25-000040 20250331 Separate Account Assets 93414000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Separate Account Assets 98948000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Separate Accounts Liability 101676000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Separate Accounts Liability 94988000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement;
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 505000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1783000000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 954000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1764000000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 219000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Temporary Equity Comprehensive Income Loss 10000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Temporary Equity Other Changes -15000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Treasury Stock Common Shares -10100000.0000 shares 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20241231 Accrued Investment Income Receivable 396000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value -4000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20241231 Assets 1873000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Management; Consolidation Items= Operating Segments;
0001535929-25-000040 20241231 Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 1665000000.0000 USD 0 0001535929-25-000040
0001535929-25-000040 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -2469000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Assets 159361000000.0000 USD 0 us-gaap/2025 Business Segments= Total Segment; Equity Components= Parent;
0001535929-25-000040 20241231 Assets 4528000000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0001535929-25-000040 20250331 Assets 23678000000.0000 USD 0 us-gaap/2025 Business Segments= Corporate;
0001535929-25-000040 20240331 Borrowingsof Consolidated Investment Entities 73000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20241231 Collateralized Financings Consolidated Investment Entities 0.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 3000000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 9000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 30050000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2116000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3486000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2472000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3471000000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 580000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 7414000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 29225000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Restricted 1523000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Debt Securities Available For Sale Restricted 1393000000.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged;
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 62000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 41000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 9000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 8000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 313000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 286000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Derivative; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 42000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 11000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20240331 Dividends Common Stock Cash 41000000.0000 USD 1 us-gaap/2025 Class Of Stock= Common Stock; Equity Components= Parent;
0001535929-25-000040 20250331 Dividends Preferred Stock Cash 13000000.0000 USD 1 us-gaap/2025 Class Of Stock= Series A Preferred Stock;
0001535929-25-000040 20250331 Dividends Preferred Stock Cash 17000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Equity Securities Fv Ni 209000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 24000000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001535929-25-000040 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 1434000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20250331 Interest Expense Other 32000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 2923000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20241231 Liabilities 394000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense 9332000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense 9214000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Long Term Debt Noncurrent 2103000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Net Income Loss Attributable To Noncontrolling Interest 37000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 141000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Investment Income 560000000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments And Corporate Non Segment;
0001535929-25-000040 20250331 Net Investment Income Consolidated Investment Entities -4000000.0000 USD 1 0001535929-25-000040 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 782000000.0000 USD 0 us-gaap/2025 Financial Instrument= Payables Under Securities Loan Agreements;
0001535929-25-000040 20240331 Oci Liability For Future Policy Benefit Gain Loss Before Reclassification Adjustment And Tax 38000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Comprehensive Income Loss Net Of Tax 281000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Other Investments 74000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Other Investments 69000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Other Liabilities 2762000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Payments For Proceeds From Short Term Investments -36000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Policyholder Contract Deposits 40549000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Premiums Receivable And Reinsurance Recoverables Including Reinsurance Premium Paid 11144000000.0000 USD 0 0001535929-25-000040
0001535929-25-000040 20250331 Proceeds From Issuance Of Common Stock 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Sale Of Available For Sale Securities Debt 1262000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Sale Of Available For Sale Securities Debt 2477000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Profit Loss 151000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 5000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20240331 Realized Investment Gains Losses 136000000.0000 USD 1 us-gaap/2025 Investment Type= Derivative;
0001535929-25-000040 20250331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20250331 Realized Investment Gains Losses -53000000.0000 USD 1 us-gaap/2025 Investment Type= Derivative;
0001535929-25-000040 20250331 Realized Investment Gains Losses -5000000.0000 USD 1 us-gaap/2025 Investment Type= Other Investments;
0001535929-25-000040 20241231 Reinsurance Recoverables Allowance 16000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Securities Purchased Under Agreements To Resell 1030000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Separate Account Assets 98948000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Separate Account Assets 2516000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Debt Securities;
0001535929-25-000040 20231231 Separate Accounts Liability 89485000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement;
0001535929-25-000040 20241231 Stockholders Equity 4005000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Stockholders Equity 4383000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5878000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6143000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2469000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 697000000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6266000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -754000000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20240331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20241231 Treasury Stock Common Shares 10095016.0000 shares 0 us-gaap/2025
0001535929-25-000040 20241231 Collateralized Financings Consolidated Investment Entities 0.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Collateralized Financings Consolidated Investment Entities 1028000000.0000 USD 0 0001535929-25-000040 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20241231 Common Stock Shares Authorized 900000000.0000 shares 0 us-gaap/2025
0001535929-25-000040 20231231 Common Stock Shares Issued 103600000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20250331 Common Stock Shares Outstanding 96200000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001535929-25-000040 20231231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 2000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 17000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 38000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 6000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 6000000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2779000000.0000 USD 0 us-gaap/2025 Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 2729000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 29000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 3578000000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 24925000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 6949000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 580000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 27454000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 401000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 29225000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3750000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 7462000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 533000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 31000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 7462000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 31000000.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Restricted 1523000000.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged;
0001535929-25-000040 20250331 Debt Securities Available For Sale Restricted 1393000000.0000 USD 0 us-gaap/2025 Collateral= Collateral Pledged; Financial Instrument= Fixed Maturities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Restricted 1393000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20250331 Deferred Income Tax Assets Net 2032000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Derivative Assets 303000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 2000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Assets 303000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Assets 62000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 40000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 41000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Liabilities 9000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Equity Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20241231 Derivative Liabilities 302000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Credit Derivatives By Contract Type= Credit Default Swap; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 42000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Dividends Preferred Stock Cash 17000000.0000 USD 1 us-gaap/2025 Class Of Stock= Preferred Stock; Equity Components= Parent;
0001535929-25-000040 20240331 Dividends Preferred Stock Cash 13000000.0000 USD 1 us-gaap/2025 Class Of Stock= Series A Preferred Stock;
0001535929-25-000040 20240331 Earnings Per Share Diluted 2.2400 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Equity Securities Fv Ni 246000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 26000000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001535929-25-000040 20231231 Goodwill 17000000.0000 USD 0 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Goodwill 73000000.0000 USD 0 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Goodwill 72000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment; Reporting Unit= Wealth Solutions Segment;
0001535929-25-000040 20250331 Income Tax Expense Benefit 22000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Interest Credited To Policyholders Account Balances 246000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240630 Interest Credited To Policyholders Account Balances 171000000.0000 USD 2 us-gaap/2025 Business Segments= Business Exited;
0001535929-25-000040 20240630 Interest Credited To Policyholders Account Balances 845000000.0000 USD 2 us-gaap/2025 Business Segments= Retirement;
0001535929-25-000040 20240331 Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities 27000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Interest Expense Other 30000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Liabilities 157589000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Minority Interest Period Increase Decrease -171000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Minority Interest Period Increase Decrease 2000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20240331 Net Cash Provided By Used In Financing Activities -1255000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss 156000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -15000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 156000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Net Investment Income 560000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Investment Income Consolidated Investment Entities 78000000.0000 USD 1 0001535929-25-000040 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Other Comprehensive Income Loss Before Tax 356000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Other Comprehensive Income Loss Net Of Tax -69000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20240331 Other Comprehensive Income Loss Tax -18000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Other Intangible Assets Net 832000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Other Liabilities 1212000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20250331 Payments For Proceeds From Derivative Instrument Investing Activities 55000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments For Repurchase Of Common Stock 0.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Policyholder Benefits And Claims Incurred Net 605000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Divestiture Of Interest In Consolidated Subsidiaries 307000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Issuance Of Common Stock 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Profit Loss 288000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses 43000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Realized Investment Gains Losses -34000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Realized Investment Gains Losses 0.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Other Derivatives Net;
0001535929-25-000040 20241231 Separate Account Assets 2493000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Debt Securities;
0001535929-25-000040 20250331 Separate Account Assets 3124000000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities Issued By Private Enterprises; Separate Account Asset Category= Separate Account Mortgage Backed Security;
0001535929-25-000040 20231231 Separate Accounts Liability 82310000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Deferred Variable Annuity;
0001535929-25-000040 20241231 Separate Accounts Liability 6901000000.0000 USD 0 us-gaap/2025 Business Segments= Retirement; Product Or Service= Wealth Solutions Stabilizer;
0001535929-25-000040 20250331 Separate Accounts Liability 3960000000.0000 USD 0 us-gaap/2025 Business Segments= All Other Segments;
0001535929-25-000040 20250331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20240331 Temporary Equity Net Income 7000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Treasury Stock Common Shares 10555992.0000 shares 0 us-gaap/2025
0001535929-25-000040 20250331 Treasury Stock Common Shares 10600000.0000 shares 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20250331 Treasury Stock Value 788000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Treasury Stock Value Acquired Cost Method 172000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001535929-25-000040 20250331 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Comprehensive Income Loss Net Of Tax Including Portion Attributable To Nonredeemable Noncontrolling Interest 422000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -5000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 219000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 38000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 18000000.0000 USD 0 us-gaap/2025 Financial Instrument= Fixed Maturities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 5275000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2412000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 70000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2537000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 30000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 472000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20241231 Debt Securities Available For Sale Excluding Accrued Interest 7008000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 3771000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 533000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 29225000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2788000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 5448000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U. S. Corporate Private Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 475000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury Securities;
0001535929-25-000040 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2621000000.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Corporate Public Securitiesand Foreign Governments;
0001535929-25-000040 20240331 Deferred Policy Acquisition Costs And Present Value Of Future Profits Amortization1 56000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20241231 Derivative Assets 55000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20241231 Derivative Assets 303000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Assets 0.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 40000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Assets 208000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 11000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Foreign Exchange Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 271000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Interest Rate Contract; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Derivative Liabilities 16000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Stabilizer And M C Gs; Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Derivative Liabilities 16000000.0000 USD 0 us-gaap/2025 Derivative Instrument Risk= Stabilizer And M C Gs; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20240331 Dividends Preferred Stock Cash 17000000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings Unappropriated;
0001535929-25-000040 20250331 Goodwill 343000000.0000 USD 0 us-gaap/2025 Business Segments= Health Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Goodwill 286000000.0000 USD 0 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Goodwill 102000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0001535929-25-000040 20240331 Increase Decrease In Collateral Held Under Securities Lending -102000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Interest Credited To Policyholders Account Balances 43000000.0000 USD 1 us-gaap/2025 Business Segments= Business Exited;
0001535929-25-000040 20241231 Investments In Affiliates Subsidiaries Associates And Joint Ventures 3067000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20241231 Liabilities 157882000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Liabilities 74000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Liabilities 220000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Loans Insurance Policy 336000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Minority Interest 1783000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Net Cash Provided By Used In Operating Activities 231000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Net Income Loss Available To Common Stockholders Basic 139000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 30000000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001535929-25-000040 20241231 Obligation To Return Securities Received As Collateral 601000000.0000 USD 0 us-gaap/2025 Financial Instrument= U. S. Corporate Public Securities;
0001535929-25-000040 20250331 Obligation To Return Securities Received As Collateral 13000000.0000 USD 0 us-gaap/2025 Financial Instrument= Short Term Investments;
0001535929-25-000040 20241231 Other Assets 2312000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001535929-25-000040 20241231 Other Assets 278000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20240331 Other Comprehensive Income Loss Before Tax -87000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Other Comprehensive Income Loss Net Of Tax 281000000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001535929-25-000040 20250331 Other Intangible Assets Net 854000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Other Investments 69000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001535929-25-000040 20240331 Other Noninterest Expense 0.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Payments For Proceeds From Other Investing Activities 18000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Payments Of Dividends Common Stock 41000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments Of Dividends Preferred Stock And Preference Stock 17000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Payments To Acquire Businesses Net Of Cash Acquired -224000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Preferred Stock Liquidation Preference Value 625000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Proceeds From Payments For Other Financing Activities -47000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Payments For Other Financing Activities -58000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Proceeds From Sale Of Loans Held For Investment 135000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20240331 Realized Investment Gains Losses -1000000.0000 USD 1 us-gaap/2025 Business Segments= Investment Management Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20240331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Standalone Derivatives;
0001535929-25-000040 20240331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Investment Type= Mortgages;
0001535929-25-000040 20240331 Realized Investment Gains Losses 2000000.0000 USD 1 us-gaap/2025 Investment Type= Other Investments;
0001535929-25-000040 20250331 Realized Investment Gains Losses -31000000.0000 USD 1 us-gaap/2025 Business Segments= Wealth Solutions Segment; Consolidation Items= Operating Segments;
0001535929-25-000040 20250331 Realized Investment Gains Losses 4000000.0000 USD 1 us-gaap/2025 Derivative Instrument Risk= Fixed Maturities;
0001535929-25-000040 20250331 Realized Investment Gains Losses 1000000.0000 USD 1 us-gaap/2025 Financial Instrument= Equity Securities;
0001535929-25-000040 20250331 Reinsurance Recoverables Allowance 17000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Repayment Of Borrowings Of Noncontrolling Interests 294000000.0000 USD 1 0001535929-25-000040
0001535929-25-000040 20241231 Securities Purchased Under Agreements To Resell 1042000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20250331 Separate Account Assets 338000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Separate Account Assets 98948000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001535929-25-000040 20250331 Separate Account Assets 177000000.0000 USD 0 us-gaap/2025 Separate Account Asset Category= Asset Backed Securities Securitized Loans And Receivables;
0001535929-25-000040 20250331 Separate Accounts Liability 98948000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6187000000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6147000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Stock Issued During Period Value New Issues 3000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001535929-25-000040 20250331 Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 214000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Treasury Stock Value Acquired Cost Method 172000000.0000 USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001535929-25-000040 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -2462000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20240331 Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings 41000000.0000 USD 1 us-gaap/2025 Class Of Stock= Common Stock;
0001535929-25-000040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 30000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001535929-25-000040 20241231 Assets 163889000000.0000 USD 0 us-gaap/2025
0001535929-25-000040 20241231 Assets 30674000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001535929-25-000040 20250331 Assets 4007000000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0001535929-25-000040 20250331 Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 1502000000.0000 USD 0 0001535929-25-000040
0001535929-25-000040 20240331 Benefits Losses And Expenses 1764000000.0000 USD 1 us-gaap/2025
0001535929-25-000040 20250331 Cash And Cash Equivalents At Carrying Value 142000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001535929-25-000040 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1118000000.0000 USD 0 us-gaap/2025

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Loans Insurance Policy us-gaap/2025 0 0 monetary I D Loans, Gross, Insurance Policy Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.
Deferred Income Tax Assets Net us-gaap/2025 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Cash And Cash Equivalents At Carrying Value us-gaap/2025 0 0 monetary I D Cash and Cash Equivalent Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Proceeds From Divestiture Of Interest In Consolidated Subsidiaries us-gaap/2025 0 0 monetary D D Proceeds from Divestiture of Interest in Consolidated Subsidiaries The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).
Proceeds From Issuance Of Common Stock us-gaap/2025 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Realized Investment Gains Losses us-gaap/2025 0 0 monetary D C Realized Investment Gains (Losses) Amount of realized gain (loss) on investment.
Benefits Losses And Expenses us-gaap/2025 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Increase Decrease In Collateral Held Under Securities Lending us-gaap/2025 0 0 monetary D C Increase (Decrease) in Collateral Held under Securities Lending The increase (decrease) during the period in the carrying amount of assets, which may include but are not limited to cash and investments, received as collateral pertaining to securities loaned to a counterparty to the transaction. Includes the change during the period in any unrealized gain or loss on such investments.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Deferred Policy Acquisition Costs And Present Value Of Future Profits Amortization1 us-gaap/2025 0 0 monetary D D Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Amortization Amount of amortization expense (reversal of expense) for deferred policy acquisition costs and present value of future profits from insurance contract acquired in business combination.
Deferred Policy Acquisition Costs And Value Of Business Acquired us-gaap/2025 0 0 monetary I D Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net Amount, after accumulated amortization, of deferred policy acquisition costs and present value of future profits from insurance contract acquired in business combination.
Other Income us-gaap/2025 0 0 monetary D C Other Income Amount of revenue and income classified as other.
Borrowingsof Consolidated Investment Entities 0001535929-25-000040 1 0 monetary D D Borrowings of Consolidated Investment Entities Borrowings of Consolidated Investment Entities
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Profit Loss us-gaap/2025 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale, Excluding Accrued Interest Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Minority Interest us-gaap/2025 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Oci Liability For Future Policy Benefit Gain Loss Before Reclassification Adjustment And Tax us-gaap/2025 0 0 monetary D C OCI, Liability for Future Policy Benefit, Gain (Loss), before Reclassification Adjustment and Tax Amount, before tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate.
Comprehensive Income Net Of Tax us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Allowance For Doubtful Other Receivables Current us-gaap/2025 0 0 monetary I C Allowance for Credit Loss, Receivable, Other, Current Amount of allowance for credit loss on receivable, classified as other and current.
Accrued Investment Income Receivable us-gaap/2025 0 0 monetary I D Accrued Investment Income Receivable Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 0 0 monetary I C Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Derivative Assets us-gaap/2025 0 0 monetary I D Derivative Asset Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.
Derivative Liabilities us-gaap/2025 0 0 monetary I C Derivative Liability Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
Interest Expense Other us-gaap/2025 0 0 monetary D D Interest Expense, Other Amount of interest expense classified as other.
Operating Expenses us-gaap/2025 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Long Term Debt Noncurrent us-gaap/2025 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Other Comprehensive Income Loss Tax us-gaap/2025 0 0 monetary D D Other Comprehensive Income (Loss), Tax Amount of tax expense (benefit) allocated to other comprehensive income (loss).
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest us-gaap/2025 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.
Other Investments us-gaap/2025 0 0 monetary I D Other Investments Amount of investments classified as other.
Proceeds From Payments To Minority Shareholders us-gaap/2025 0 0 monetary D D Proceeds from (Payments to) Noncontrolling Interests Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.
Payments For Repurchase Of Common Stock us-gaap/2025 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Other Assets us-gaap/2025 0 0 monetary I D Other Assets Amount of assets classified as other.
Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2025 0 0 monetary D C Payments to Acquire Businesses, Net of Cash Acquired The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Repayments Of Debt Maturing In More Than Three Months us-gaap/2025 0 0 monetary D C Repayments of Debt, Maturing in More than Three Months The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months. Includes repayments of short-term and long-term debt.
Retained Earnings Unappropriated us-gaap/2025 0 0 monetary I C Retained Earnings, Unappropriated Amount of accumulated undistributed earnings (deficit) available for dividend distribution. Includes, but is not limited to, retained earnings not appropriated for specific business purpose.
Payments For Proceeds From Other Investing Activities us-gaap/2025 0 0 monetary D C Payment for (Proceeds from) Other Investing Activity Amount of cash (inflow) outflow from investing activity, classified as other.
Employee Benefits And Share Based Compensation us-gaap/2025 0 0 monetary D D Employee Benefits and Share-Based Compensation Amount of expense for employee benefit and equity-based compensation.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Net Investment Income us-gaap/2025 0 0 monetary D C Net Investment Income Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.
Other Noninterest Expense us-gaap/2025 0 0 monetary D D Other Noninterest Expense Amount of noninterest expense classified as other.
Payments To Acquire Available For Sale Securities Debt us-gaap/2025 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Preferred Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Premiums Earned Net us-gaap/2025 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Other Comprehensive Income Loss Before Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), before Tax Amount before tax, after reclassification adjustments of other comprehensive income (loss).
Proceeds From Sale Of Loans Held For Investment us-gaap/2025 0 0 monetary D D Proceeds from Sale, Loan, Held-for-Investment Amount of cash inflow from sale of loan held for investment.
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests us-gaap/2025 0 0 monetary I C Temporary Equity, Including Noncontrolling Interest Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
Insurance Commissions And Fees us-gaap/2025 0 0 monetary D C Insurance Commissions and Fees Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products.
Available For Sale Securities Debt Securities Using Fair Value Option 0001535929-25-000040 1 0 monetary I D Available-for-sale Securities, Debt Securities, using Fair Value Option Available-for-sale Securities, Debt Securities, using Fair Value Option
Collateralized Financings Consolidated Investment Entities 0001535929-25-000040 1 0 monetary I C Collateralized Financings, Consolidated Investment Entities Collateralized Financings, Consolidated Investment Entities
Premiums Receivable And Reinsurance Recoverables Including Reinsurance Premium Paid 0001535929-25-000040 1 0 monetary I D Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Other Intangible Assets Net us-gaap/2025 0 0 monetary I D Other Intangible Assets, Net Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.
Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 0001535929-25-000040 1 0 monetary I D Available-for-sale Securities, Pledged as Collateral, Debt Securities, Amortized Cost This item represents the cost of debt and equity securities pledged as collateral, which are categorized neither as held-to-maturity nor trading, net of adjustments made for accretion, amortization, other-than-temporary impairments, and hedging, if any.
Payments To Acquire Assets Investing Activities us-gaap/2025 0 0 monetary D C Payments to Acquire Assets, Investing Activities Aggregate cash payments for a combination of transactions that are classified as investing activities in which assets, which may include securities, other types of investments, or productive assets, are purchased from third-party sellers. This element can be used by entities to aggregate payments for all asset purchases that are classified as investing activities.
Payments To Acquire Equity Securities Fv Ni us-gaap/2025 0 0 monetary D C Payments to Acquire Equity Securities, FV-NI Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Proceeds From Limited Partnership Investments us-gaap/2025 0 0 monetary D D Proceeds from Limited Partnership Investments Cash inflow received as distributions, returns of capital, or sale proceeds from partnership interests held for investment purposes.
Comprehensive Income Loss Net Of Tax Including Portion Attributable To Nonredeemable Noncontrolling Interest 0001535929-25-000040 1 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest
Separate Account Assets us-gaap/2025 0 0 monetary I D Separate Account Asset Amount of asset at fair value held for benefit of separate account policyholder.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings us-gaap/2025 0 0 monetary D D Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.
Dividends Common Stock Cash us-gaap/2025 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Investments us-gaap/2025 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Short Term Borrowings us-gaap/2025 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Temporary Equity Other Changes us-gaap/2025 0 0 monetary D C Temporary Equity, Other Changes Amount of increase (decrease) in temporary equity from changes classified as other.
Temporary Equity Comprehensive Income Loss 0001535929-25-000040 1 0 monetary D C Temporary Equity, Comprehensive Income (Loss) Temporary Equity, Comprehensive Income (Loss)
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Dividends Preferred Stock us-gaap/2025 0 0 monetary D D Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Cash Acquired From Acquisition us-gaap/2025 0 0 monetary D D Cash Acquired from Acquisition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).
Equity Securities Fv Ni us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI, Current Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.
Interest Credited To Policyholders Account Balances us-gaap/2025 0 0 monetary D D Policyholder Account Balance, Interest Expense Amount of interest expense for allocation to policyholder account balance.
Goodwill us-gaap/2025 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities us-gaap/2025 0 0 monetary D D Interest Expense, Beneficial Interests Issued by Consolidated Variable Interest Entities Interest expense on beneficial interests issued by consolidated variable interest entities.
Payments To Acquire Limited Partnership Interests us-gaap/2025 0 0 monetary D C Payments to Acquire Limited Partnership Interests Cash outflow related to the acquisition or continued holding of limited partnership interests held for investment purposes.
Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Payments To Acquire Mortgage Notes Receivable us-gaap/2025 0 0 monetary D C Payments to Acquire Mortgage Notes Receivable The cash outflow from the purchase of receivables arising from the mortgage note on real estate.
Policyholder Contract Deposits us-gaap/2025 0 0 monetary I C Policyholder Contract Deposit Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity.
Preferred Stock Liquidation Preference Value us-gaap/2025 0 0 monetary I C Preferred Stock, Liquidation Preference, Value Value of the difference between preference in liquidation and the par or stated values of the preferred shares.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Securities Purchased Under Agreements To Resell us-gaap/2025 0 0 monetary I D Securities Purchased under Agreements to Resell Amount, after the effects of master netting arrangements, of funds outstanding loaned in the form of a security resale agreement between the entity and another party for the purchase and resale of identical or substantially the same securities at a date certain for a specified price. Includes purchases of participations in pools of securities that are subject to a resale agreement, assets not subject to a master netting arrangement and not elected to be offset.
Revenues us-gaap/2025 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2025 0 0 monetary I D Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.
Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense us-gaap/2025 0 0 monetary I C Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense The aggregate amount of policy reserves (provided for future obligations including unpaid claims and claims adjustment expenses) and policy benefits (liability for future policy benefits) as of the balance sheet date; grouped amount of all the liabilities associated with the company's insurance policies.
Payments For Proceeds From Short Term Investments us-gaap/2025 0 0 monetary D C Payments for (Proceeds from) Short-Term Investments The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, before Tax, Portion Attributable to Parent Amount, before tax and after reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.
Other Short Term Investments us-gaap/2025 0 0 monetary I D Other Short-Term Investments Amount of short-term investments classified as other.
Proceeds From Other Deposits us-gaap/2025 0 0 monetary D D Proceeds from Other Deposits Amount of cash inflow for receipts of deposits classified as other.
Payments For Proceeds From Derivative Instrument Investing Activities us-gaap/2025 0 0 monetary D C Payments for (Proceeds from) Derivative Instrument, Investing Activities The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.
Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 0 0 monetary D D Proceeds from Sale of Debt Securities, Available-for-Sale Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Net Investment Income Consolidated Investment Entities 0001535929-25-000040 1 0 monetary D C Net Investment Income, Consolidated Investment Entities Net Investment Income, Consolidated Investment Entities
Treasury Stock Common Shares us-gaap/2025 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Value Acquired Cost Method us-gaap/2025 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Additional Paid In Capital Common Stock us-gaap/2025 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Treasury Stock Value us-gaap/2025 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Debt Securities Available For Sale Restricted us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale, Restricted Amount of restricted investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Dividends Preferred Stock Cash us-gaap/2025 0 0 monetary D D Dividends, Preferred Stock, Cash Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 0 0 monetary I C Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.
Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2025 0 0 monetary I D Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Amount of investment in equity method investee and investment in and advance to affiliate.
Minority Interest Period Increase Decrease us-gaap/2025 0 0 monetary D Noncontrolling Interest, Period Increase (Decrease) Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.
Net Income Loss Available To Common Stockholders Basic us-gaap/2025 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Obligation To Return Securities Received As Collateral us-gaap/2025 0 0 monetary I C Obligation to Return Securities Received as Collateral The fair value of collateral received by the entity associated with securities borrowed that must be returned if the counterparty fulfills its obligations. It appears on the balance sheet as a liability and has a corresponding asset that appears on the balance sheet called Securities Received as Collateral.
Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2025 0 0 monetary D C Payments of Ordinary Dividends, Preferred Stock and Preference Stock Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.
Policyholder Benefits And Claims Incurred Net us-gaap/2025 0 0 monetary D D Policyholder Benefits and Claims Incurred, Net Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.
Preferred Stock Value us-gaap/2025 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Payments For Other Financing Activities us-gaap/2025 0 0 monetary D D Proceeds from (Payment for) Other Financing Activity Amount of cash inflow (outflow) from financing activity, classified as other.
Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 0 0 monetary D D Proceeds from Sale of Equity Securities, FV-NI Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Temporary Equity Net Income us-gaap/2025 0 0 monetary D C Temporary Equity, Net Income The portion of net income or loss attributable to temporary equity interest.
Withdrawal From Contract Holders Funds us-gaap/2025 0 0 monetary D C Withdrawal from Contract Holders Funds The cash outflow for a segregated fund account during the period.
Repayment Of Borrowings Of Noncontrolling Interests 0001535929-25-000040 1 0 monetary D C Repayment Of Borrowings Of Noncontrolling Interests Repayment Of Borrowings Of Noncontrolling Interests
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Stock Issued During Period Value New Issues us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Additions To Contract Holders Funds us-gaap/2025 0 0 monetary D D Additions to Contract Holders Funds The cash inflow from a segregated fund account during the period.
Reinsurance Recoverables Allowance us-gaap/2025 0 0 monetary I C Reinsurance Recoverable, Allowance for Credit Loss Amount of allowance for credit loss on reinsurance recoverable.
Other Liabilities us-gaap/2025 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Payments Of Dividends Common Stock us-gaap/2025 0 0 monetary D C Payments of Ordinary Dividends, Common Stock Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
Separate Accounts Liability us-gaap/2025 0 0 monetary I C Separate Account, Liability Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001535929-25-000040 4 9 IS 0 H Revenues us-gaap/2025 Total revenues 0
0001535929-25-000040 4 6 IS 0 H Other Income us-gaap/2025 Other revenue 0
0001535929-25-000040 2 9 BS 0 H Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2025 Fixed maturities, available-for-sale, at fair value (amortized cost of $28,079 and $26,536 as of 2025 and 2024, respectively; net of allowance for credit losses of $18 and $38 as of 2025 and 2024, respectively) 0
0001535929-25-000040 2 10 BS 0 H Available For Sale Securities Debt Securities Using Fair Value Option 0001535929-25-000040 Fixed maturities, at fair value using the fair value option 0
0001535929-25-000040 2 11 BS 0 H Equity Securities Fv Ni us-gaap/2025 Equity securities, at fair value 0
0001535929-25-000040 2 12 BS 0 H Other Short Term Investments us-gaap/2025 Short-term investments 0
0001535929-25-000040 2 13 BS 0 H Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2025 Mortgage loans on real estate (net of allowance for credit losses of $29 and $24 as of 2025 and 2024, respectively) 0
0001535929-25-000040 2 14 BS 0 H Loans Insurance Policy us-gaap/2025 Policy loans 0
0001535929-25-000040 2 15 BS 0 H Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2025 Limited partnerships/corporations 0
0001535929-25-000040 2 16 BS 0 H Derivative Assets us-gaap/2025 Derivatives 0
0001535929-25-000040 2 17 BS 0 H Other Investments us-gaap/2025 Other investments 0
0001535929-25-000040 2 18 BS 0 H Debt Securities Available For Sale Restricted us-gaap/2025 Securities pledged (amortized cost of $1,502 and $1,665 as of 2025 and 2024, respectively) 0
0001535929-25-000040 2 19 BS 0 H Investments us-gaap/2025 Total investments 0
0001535929-25-000040 2 20 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001535929-25-000040 4 8 IS 0 H Net Investment Income Consolidated Investment Entities 0001535929-25-000040 Net investment income 0
0001535929-25-000040 2 21 BS 0 H Securities Purchased Under Agreements To Resell us-gaap/2025 Short-term investments under securities loan agreements, including collateral delivered 0
0001535929-25-000040 2 22 BS 0 H Accrued Investment Income Receivable us-gaap/2025 Accrued investment income 0
0001535929-25-000040 2 23 BS 0 H Premiums Receivable And Reinsurance Recoverables Including Reinsurance Premium Paid 0001535929-25-000040 Premium receivable and reinsurance recoverable (net of allowance for credit losses of $17 and $16 as of 2025 and 2024, respectively) 0
0001535929-25-000040 2 24 BS 0 H Deferred Policy Acquisition Costs And Value Of Business Acquired us-gaap/2025 Deferred policy acquisition costs ("DAC") and Value of business acquired ("VOBA") 0
0001535929-25-000040 2 25 BS 0 H Deferred Income Tax Assets Net us-gaap/2025 Deferred income taxes 0
0001535929-25-000040 2 26 BS 0 H Goodwill us-gaap/2025 Goodwill 0
0001535929-25-000040 2 27 BS 0 H Other Intangible Assets Net us-gaap/2025 Other intangibles, net 0
0001535929-25-000040 2 28 BS 0 H Other Assets us-gaap/2025 Other assets 0
0001535929-25-000040 2 29 BS 0 H Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2025 Corporate loans, at fair value using the fair value option 0
0001535929-25-000040 2 30 BS 0 H Separate Account Assets us-gaap/2025 Assets held in separate accounts 0
0001535929-25-000040 2 31 BS 0 H Assets us-gaap/2025 Total assets 0
0001535929-25-000040 2 33 BS 0 H Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense us-gaap/2025 Future policy benefits 0
0001535929-25-000040 2 34 BS 0 H Policyholder Contract Deposits us-gaap/2025 Contract owner account balances 0
0001535929-25-000040 2 35 BS 0 H Obligation To Return Securities Received As Collateral us-gaap/2025 Payables under securities loan and repurchase agreements, including collateral held 0
0001535929-25-000040 2 36 BS 0 H Short Term Borrowings us-gaap/2025 Short-term debt 0
0001535929-25-000040 2 37 BS 0 H Long Term Debt Noncurrent us-gaap/2025 Long-term debt 0
0001535929-25-000040 2 38 BS 0 H Derivative Liabilities us-gaap/2025 Derivatives 0
0001535929-25-000040 2 39 BS 0 H Other Liabilities us-gaap/2025 Other liabilities 0
0001535929-25-000040 2 40 BS 0 H Collateralized Financings Consolidated Investment Entities 0001535929-25-000040 Collateralized loan obligations notes, at fair value using the fair value option 0
0001535929-25-000040 2 41 BS 0 H Separate Accounts Liability us-gaap/2025 Liabilities related to separate accounts 0
0001535929-25-000040 2 42 BS 0 H Liabilities us-gaap/2025 Total liabilities 0
0001535929-25-000040 2 43 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and Contingencies (Note 18) 0
0001535929-25-000040 2 45 BS 0 H Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests us-gaap/2025 Redeemable noncontrolling interest 0
0001535929-25-000040 2 47 BS 0 H Preferred Stock Value us-gaap/2025 Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2025 and 2024) 0
0001535929-25-000040 2 48 BS 0 H Common Stock Value us-gaap/2025 Common stock ($0.01 par value per share; 900,000,000 shares authorized; 106,813,254 and 105,592,281 shares issued as of 2025 and 2024, respectively; 96,257,262 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) 0
0001535929-25-000040 2 49 BS 0 H Treasury Stock Value us-gaap/2025 Treasury stock (at cost; 10,555,992 and 10,095,016 shares as of 2025 and 2024, respectively) 1
0001535929-25-000040 2 50 BS 0 H Additional Paid In Capital Common Stock us-gaap/2025 Additional paid-in capital 0
0001535929-25-000040 2 51 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Accumulated other comprehensive income (loss) 0
0001535929-25-000040 2 53 BS 0 H Retained Earnings Unappropriated us-gaap/2025 Unappropriated 0
0001535929-25-000040 2 54 BS 0 H Stockholders Equity us-gaap/2025 Total Voya Financial, Inc. shareholders' equity 0
0001535929-25-000040 2 55 BS 0 H Minority Interest us-gaap/2025 Noncontrolling interest 0
0001535929-25-000040 2 56 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Total shareholders' equity 0
0001535929-25-000040 2 57 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total liabilities, mezzanine equity and shareholders' equity 0
0001535929-25-000040 3 1 BS 1 H Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2025 Fixed maturities, Amortized Cost 0
0001535929-25-000040 3 2 BS 1 H Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 Fixed maturities, allowance for credit losses 0
0001535929-25-000040 3 3 BS 1 H Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 Mortgage loans, allowance for credit losses 0
0001535929-25-000040 3 4 BS 1 H Available For Sale Securities Pledged As Collateral Debt Securities Amortized Cost 0001535929-25-000040 Securities pledged, amortized cost 0
0001535929-25-000040 3 5 BS 1 H Reinsurance Recoverables Allowance us-gaap/2025 Premium receivable and reinsurance recoverable, allowance for credit losses 0
0001535929-25-000040 3 6 BS 1 H Allowance For Doubtful Other Receivables Current us-gaap/2025 Other assets, allowance for credit losses 0
0001535929-25-000040 3 7 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2025 Preferred stock, par value (usd per share) 0
0001535929-25-000040 3 8 BS 1 H Preferred Stock Liquidation Preference Value us-gaap/2025 Preferred stock, aggregate liquidation preference 0
0001535929-25-000040 3 9 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (usd per share) 0
0001535929-25-000040 3 10 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares outstanding (in shares) 0
0001535929-25-000040 3 11 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued (in shares) 0
0001535929-25-000040 3 12 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding (in shares) 0
0001535929-25-000040 3 13 BS 1 H Treasury Stock Common Shares us-gaap/2025 Treasury stock (in shares) 0
0001535929-25-000040 4 2 IS 0 H Net Investment Income us-gaap/2025 Net investment income 0
0001535929-25-000040 4 3 IS 0 H Insurance Commissions And Fees us-gaap/2025 Fee income 0
0001535929-25-000040 4 4 IS 0 H Premiums Earned Net us-gaap/2025 Premiums 0
0001535929-25-000040 4 5 IS 0 H Realized Investment Gains Losses us-gaap/2025 Net gains (losses) 0
0001535929-25-000040 4 11 IS 0 H Policyholder Benefits And Claims Incurred Net us-gaap/2025 Policyholder benefits 0
0001535929-25-000040 4 12 IS 0 H Interest Credited To Policyholders Account Balances us-gaap/2025 Interest credited to contract owner account balances 0
0001535929-25-000040 4 13 IS 0 H Operating Expenses us-gaap/2025 Operating expenses 0
0001535929-25-000040 4 14 IS 0 H Deferred Policy Acquisition Costs And Present Value Of Future Profits Amortization1 us-gaap/2025 Net amortization of DAC and VOBA 0
0001535929-25-000040 4 15 IS 0 H Interest Expense Other us-gaap/2025 Interest expense 0
0001535929-25-000040 4 17 IS 0 H Interest Expense Beneficial Interests Issued By Consolidated Variable Interest Entities us-gaap/2025 Interest expense 0
0001535929-25-000040 4 18 IS 0 H Other Noninterest Expense us-gaap/2025 Other expense 0
0001535929-25-000040 4 19 IS 0 H Benefits Losses And Expenses us-gaap/2025 Total benefits and expenses 0
0001535929-25-000040 4 20 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 Income before income taxes 0
0001535929-25-000040 4 21 IS 0 H Income Tax Expense Benefit us-gaap/2025 Income tax expense (benefit) 0
0001535929-25-000040 4 22 IS 0 H Profit Loss us-gaap/2025 Net income (loss) 0
0001535929-25-000040 4 23 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 Less: Net income (loss) attributable to noncontrolling interest 0
0001535929-25-000040 4 24 IS 0 H Net Income Loss us-gaap/2025 Net income (loss) available to Voya Financial, Inc. 0
0001535929-25-000040 4 25 IS 0 H Dividends Preferred Stock us-gaap/2025 Less: Preferred stock dividends 0
0001535929-25-000040 4 26 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2025 Net income (loss) available to Voya Financial, Inc.'s common shareholders 0
0001535929-25-000040 4 28 IS 0 H Earnings Per Share Basic us-gaap/2025 Basic (usd per share) 0
0001535929-25-000040 4 29 IS 0 H Earnings Per Share Diluted us-gaap/2025 Diluted (usd per share) 0
0001535929-25-000040 5 1 CI 0 H Profit Loss us-gaap/2025 Net income (loss) 0
0001535929-25-000040 5 3 CI 0 H Oci Liability For Future Policy Benefit Gain Loss Before Reclassification Adjustment And Tax us-gaap/2025 Change in current discount rate 0
0001535929-25-000040 5 4 CI 0 H Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent us-gaap/2025 Unrealized gains (losses) on investments 0
0001535929-25-000040 5 5 CI 0 H Other Comprehensive Income Loss Before Tax us-gaap/2025 Other comprehensive income (loss), before tax 0
0001535929-25-000040 5 6 CI 0 H Other Comprehensive Income Loss Tax us-gaap/2025 Income tax expense (benefit) related to items of other comprehensive income (loss) 0
0001535929-25-000040 5 7 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss), after tax 0
0001535929-25-000040 5 8 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Comprehensive income 0
0001535929-25-000040 5 9 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 0
0001535929-25-000040 5 10 CI 0 H Comprehensive Income Net Of Tax us-gaap/2025 Comprehensive income attributable to Voya Financial, Inc. 0
0001535929-25-000040 6 17 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Beginning balance 0
0001535929-25-000040 6 19 EQ 0 H Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest us-gaap/2025 Net income (loss) 0
0001535929-25-000040 6 20 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss), after tax 0
0001535929-25-000040 6 21 EQ 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Total comprehensive income (loss) 0
0001535929-25-000040 6 22 EQ 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 Total comprehensive income (loss) 0
0001535929-25-000040 6 23 EQ 0 H Comprehensive Income Loss Net Of Tax Including Portion Attributable To Nonredeemable Noncontrolling Interest 0001535929-25-000040 Total comprehensive income (loss) 0
0001535929-25-000040 6 24 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2025 Common stock issuance 0
0001535929-25-000040 6 25 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2025 Common stock acquired - Share repurchase 1
0001535929-25-000040 6 26 EQ 0 H Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings us-gaap/2025 Dividends 1
0001535929-25-000040 6 27 EQ 0 H Dividends Preferred Stock Cash us-gaap/2025 Dividends on preferred stock 1
0001535929-25-000040 6 28 EQ 0 H Dividends Common Stock Cash us-gaap/2025 Dividends on common stock 1
0001535929-25-000040 6 29 EQ 0 H Employee Benefits And Share Based Compensation us-gaap/2025 Employee Benefits and Share-Based Compensation 0
0001535929-25-000040 6 30 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 Share-based compensation 0
0001535929-25-000040 6 31 EQ 0 H Minority Interest Period Increase Decrease us-gaap/2025 Contributions from (Distributions to) noncontrolling interest, net 0
0001535929-25-000040 6 32 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Ending balance 0
0001535929-25-000040 6 34 EQ 0 H Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests us-gaap/2025 Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning balance 0
0001535929-25-000040 6 35 EQ 0 H Temporary Equity Net Income us-gaap/2025 Net income 0
0001535929-25-000040 6 36 EQ 0 H Temporary Equity Comprehensive Income Loss 0001535929-25-000040 Total comprehensive income (loss) 0
0001535929-25-000040 6 37 EQ 0 H Temporary Equity Other Changes us-gaap/2025 Contributions from (Distributions to) noncontrolling interest, net 0
0001535929-25-000040 6 38 EQ 0 H Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests us-gaap/2025 Mezzanine Equity: Redeemable Noncontrolling Interest, Ending balance 0
0001535929-25-000040 7 2 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash provided by (used in) operating activities 0
0001535929-25-000040 7 5 CF 0 H Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 Fixed maturities 0
0001535929-25-000040 7 6 CF 0 H Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 Equity securities 0
0001535929-25-000040 7 7 CF 0 H Proceeds From Sale Of Loans Held For Investment us-gaap/2025 Mortgage loans on real estate 0
0001535929-25-000040 7 8 CF 0 H Proceeds From Limited Partnership Investments us-gaap/2025 Limited partnerships/corporations 0
0001535929-25-000040 7 10 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2025 Fixed maturities 1
0001535929-25-000040 7 11 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2025 Equity securities 1
0001535929-25-000040 7 12 CF 0 H Payments To Acquire Mortgage Notes Receivable us-gaap/2025 Mortgage loans on real estate 1
0001535929-25-000040 7 13 CF 0 H Payments To Acquire Limited Partnership Interests us-gaap/2025 Limited partnerships/corporations 1
0001535929-25-000040 7 14 CF 0 H Payments For Proceeds From Short Term Investments us-gaap/2025 Short-term investments, net 1
0001535929-25-000040 7 15 CF 0 H Payments For Proceeds From Derivative Instrument Investing Activities us-gaap/2025 Derivatives, net 1
0001535929-25-000040 7 16 CF 0 H Proceeds From Divestiture Of Interest In Consolidated Subsidiaries us-gaap/2025 Sales from CIEs 0
0001535929-25-000040 7 17 CF 0 H Payments To Acquire Assets Investing Activities us-gaap/2025 Purchases within CIEs 1
0001535929-25-000040 7 18 CF 0 H Increase Decrease In Collateral Held Under Securities Lending us-gaap/2025 Collateral received (delivered), net 1
0001535929-25-000040 7 19 CF 0 H Proceeds From Other Deposits us-gaap/2025 Receipts on deposit asset contracts 0
0001535929-25-000040 7 20 CF 0 H Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2025 Cash and cash equivalents acquired from business acquisitions, net of cash paid 1
0001535929-25-000040 7 21 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2025 Other, net 1
0001535929-25-000040 7 22 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash provided by (used in) investing activities 0
0001535929-25-000040 7 24 CF 0 H Additions To Contract Holders Funds us-gaap/2025 Deposits received for investment contracts 0
0001535929-25-000040 7 25 CF 0 H Withdrawal From Contract Holders Funds us-gaap/2025 Maturities and withdrawals from investment contracts 1
0001535929-25-000040 7 26 CF 0 H Repayments Of Debt Maturing In More Than Three Months us-gaap/2025 Repayments of long-term debt, including current maturities 1
0001535929-25-000040 7 27 CF 0 H Borrowingsof Consolidated Investment Entities 0001535929-25-000040 Borrowings of CIEs 0
0001535929-25-000040 7 28 CF 0 H Repayment Of Borrowings Of Noncontrolling Interests 0001535929-25-000040 Repayments of borrowings of CIEs 1
0001535929-25-000040 7 29 CF 0 H Proceeds From Payments To Minority Shareholders us-gaap/2025 Contributions from (distributions to) participants in CIEs, net 0
0001535929-25-000040 7 30 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2025 Proceeds from issuance of common stock, net 0
0001535929-25-000040 7 31 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2025 Common stock acquired - Share repurchase 1
0001535929-25-000040 7 32 CF 0 H Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2025 Dividends paid on preferred stock 1
0001535929-25-000040 7 33 CF 0 H Payments Of Dividends Common Stock us-gaap/2025 Dividends paid on common stock 1
0001535929-25-000040 7 34 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2025 Other, net 0
0001535929-25-000040 7 35 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash provided by (used in) financing activities 0
0001535929-25-000040 7 36 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 Net increase (decrease) in cash and cash equivalents, including cash in CIEs 0
0001535929-25-000040 7 37 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 Cash and cash equivalents, including cash in CIEs, beginning of period 0
0001535929-25-000040 7 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2025 Cash and cash equivalents, including cash in CIEs, end of period 0
0001535929-25-000040 7 46 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001535929-25-000040 7 47 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Total cash and cash equivalents, including cash in CIEs 0
0001535929-25-000040 8 1 CF 1 H Cash Acquired From Acquisition us-gaap/2025 Cash acquired from acquisition 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.